Alkeon Capital Management Llc - Dec 31, 2024 SCHEDULE 13G Report for Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share (KROS)

Filing Manager: ALKEON CAPITAL MANAGEMENT LLC
Reporting Manager: Alkeon Capital Management LLC
Security: Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: KROS
Shares outstanding: 40.8M shares
Disclosed Ownership: 1.1M shares
Ownership: 2.7%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 04:12 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Alkeon Capital Management LLC	2.7%	1.1M	0	1.1M	/s/ Jennifer Shufro	Jennifer Shufro, Compliance Officer
Panayotis D. Sparaggis	2.7%	1.1M	0	1.1M	/s/ Panayotis D. Sparaggis	Panayotis D. Sparaggis, individually